by Stephanie Law, Amy S Piatek, Cheri Vincent et al.
The Lancet Public Health, Vol. 2, No. 1, e47–e55, January 2017
India has the highest number of patients with tuberculosis and multidrug-resistant tuberculosis in the world. The authors used a transmission model to project the emergence of drug resistance in India due to incorrect tuberculosis management practices in multiple sectors, including public and private providers, chemists, and non-allopathic practitioners. The authors predict a gradual transformation from the current epidemic of drug-susceptible tuberculosis to a drug-resistant epidemic. Evidence-based strategies to improve provider practices and patient adherence across health sectors are urgently needed to prevent this.